26-07-2011: Novozymes Biopharma, part of Novozymes A/S, received the 2011 Nottingham Evening Post (NEP) Business Award in the business innovation category, for its recombinant human albumin range. The company has been recognized for its outstanding contribution to pushing back scientific frontiers by developing innovative, process improving solutions for the medical device and pharmaceutical manufacturing industries. The NEP business awards are designed to reward organizations in the region for setting new benchmarks in their industries and the company is delighted to add this accolade to its growing collection of awards.
“Novozymes Biopharma is pleased to have been selected for the business innovation award”, comments Sally Vernon, Customer Communications Manager, Novozymes Biopharma. “We have a great infrastructure in the business and a dedication to science which is what makes us important to our customers. We are committed to working with customers to improve their products and processes and with the large pharmaceutical companies looking to reformulate many of their patents, we can support them by giving them the edge over their competitors.”
Novozymes and Terranol, a Denmark-based biotechnology company specialized in yeast, announced an agreement that will ensure the final optimization of the Terranol C5 yeast strain and give Novozymes the rights to register and market Terranol’s C5 yeast technology. C5 yeast is an essential co ... more
BASF, Cargill and Novozymes have signed an agreement to develop technologies to produce acrylic acid from renewable raw materials.Presently, acrylic acid is produced by the oxidation of propylene derived from the refining of crude oil. BASF, Cargill and Novozymes will develop bio-based tech ... more
Novozymes has succeeded in developing a fungus that enables production of malic acid from renewable raw materials instead of oil. Malic acid is used as a flavor enhancer in the food industry and can be converted into other chemical derivatives used for a variety of plastic, polymer and resi ... more
Novozymes is the world leader in bio-innovations. Together with customers across a broad array of industries, we create tomorrow's industrial bio-solutions, which both improves our customers' business and the use of the planet's resources more